|
CDK6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.966300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.041100E-04 |
| Normal-vs-Stage2 |
4.285599999998E-05 |
| Normal-vs-Stage3 |
4.303900E-03 |
| Normal-vs-Stage4 |
8.173200E-01 |
| Stage1-vs-Stage2 |
4.302500E-02 |
| Stage1-vs-Stage3 |
7.218000E-01 |
| Stage1-vs-Stage4 |
1.084640E-01 |
| Stage2-vs-Stage3 |
1.605410E-01 |
| Stage2-vs-Stage4 |
7.984500E-03 |
| Stage3-vs-Stage4 |
9.986100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.632400E-04 |
| Normal-vs-AfricanAmerican |
5.703800E-03 |
| Normal-vs-Asian |
4.144600E-01 |
| Caucasian-vs-AfricanAmerican |
5.412000E-01 |
| Caucasian-vs-Asian |
2.087400E-01 |
| AfricanAmerican-vs-Asian |
1.761760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.219790E-03 |
| Normal-vs-Female |
1.217220E-03 |
| Male-vs-Female |
7.880400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.843800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.153760E-04 |
| Normal-vs-Age(61-80Yrs) |
3.123600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.71280000019303E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.384970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.851000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.556100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.087200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.097600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.378760E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.862410E-01 |
| Normal-vs-Grade 2 |
3.462000E-03 |
| Normal-vs-Grade 3 |
9.85729999958274E-07 |
| Normal-vs-Grade 4 |
8.867000E-01 |
| Grade 1-vs-Grade 2 |
7.711000E-01 |
| Grade 1-vs-Grade 3 |
7.151200E-01 |
| Grade 1-vs-Grade 4 |
3.141200E-01 |
| Grade 2-vs-Grade 3 |
6.174000E-02 |
| Grade 2-vs-Grade 4 |
2.407800E-01 |
| Grade 3-vs-Grade 4 |
5.451600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.63810000000698E-05 |
| Normal-vs-ccB subtype |
2.981900E-02 |
| ccA subtype-vs-ccB subtype |
2.450800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.994490E-04 |
| Normal-vs-N1 |
2.229400E-01 |
| N0-vs-N1 |
9.536200E-02 |
|
|
